Up-regulation of hMUTYH, a DNA repair enzyme, in the mitochondria of substantia nigra in Parkinson's disease

被引:48
|
作者
Arai, Takeo
Fukae, Jiro
Hatano, Taku
Kubo, Shin-ichiro
Ohtsubo, Toshio
Nakabeppu, Yusaku
Mori, Hideo
Mizuno, Yoshikuni
Hattori, Nobutaka
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka 8128582, Japan
关键词
Parkinson's disease; oxidative stress; hMUTYH; DNA repair enzyme;
D O I
10.1007/s00401-006-0081-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is ample evidence for the involvement of oxidative stress in mitochondrial DNA damage and repair mechanisms in Parkinson's disease (PD). The human MutY homolog (hMUTYH) which removes misincorporated adenine opposite 8-oxoG in DNA functions in post-replication, and is localized in the nuclei and mitochondria. We hypothesized that hMUTYH is involved in the disease process of PD. To test our hypothesis, we performed immunohistochemical and biochemical studies on brains of patients with PD and those of control patients. Our results showed up-regulation of hMUTYH in the mitochondria of the SN of PD patients. Western blot analysis also revealed high hMUTYH levels in PD patients and expression of a 47-kDa molecule in the brains as the major isoform. This molecule was localized within the mitochondria as confirmed by double staining with a mitochondrial marker. To confirm the presence of this molecule, we examined the mRNAs of isoforms that translate to the 47-kDa molecule. Based on the amount of mRNAs, the major molecule was alpha 4. Interestingly, this molecule lacks the mitochondria targeting sequence. Our results suggest that hMUTYH might be a useful marker of oxidative stress and that oxidative stress and genomic instability are important in the PD disease process.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [21] Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review
    Feraco, Paola
    Gagliardo, Cesare
    La Tona, Giuseppe
    Bruno, Eleonora
    D'angelo, Costanza
    Marrale, Maurizio
    Del Poggio, Anna
    Malaguti, Maria Chiara
    Geraci, Laura
    Baschi, Roberta
    Petralia, Benedetto
    Midiri, Massimo
    Monastero, Roberto
    BRAIN SCIENCES, 2021, 11 (06)
  • [22] No evidence of substantia nigra telomere shortening in Parkinson's disease
    Hudson, Gavin
    Faini, David
    Stutt, Andrea
    Eccles, Martin
    Robinson, Louise
    Burn, David J.
    Chinnery, Patrick F.
    NEUROBIOLOGY OF AGING, 2011, 32 (11) : 2107.e3 - 2107.e5
  • [23] Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no
    Uwe Walter
    Journal of Neural Transmission, 2011, 118 : 607 - 612
  • [24] Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
    Fabbri, Margherita
    Reimao, Sofia
    Carvalho, Miguel
    Nunes, Rita G.
    Abreu, Daisy
    Guedes, Leonor Correia
    Bouca, Raquel
    Lobo, Patricia P.
    Godinho, Catarina
    Coelho, Miguel
    Goncalves, Nilza C.
    Rosa, Mario Miguel
    Antonini, Angelo
    Ferreira, Joaquim J.
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (03) : 491 - 501
  • [25] Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
    Berg, D
    Metz, B
    Reiners, K
    Naumann, M
    Becker, G
    MOVEMENT DISORDERS, 2005, 20 (03) : 383 - 385
  • [26] Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease
    Fan, Yongyan
    Ma, Jianjun
    Yang, Dawei
    Li, Xiaohuan
    Liang, Keke
    She, Zonghan
    Qi, Xuelin
    Shi, Xiaoxue
    Gu, Qi
    Zheng, Jinhua
    Li, Dongsheng
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (10) : 2702 - 2714
  • [27] Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease
    Zhou, Hai-Yan
    Huang, Pei
    Sun, Qian
    Du, Juan-Juan
    Cui, Shi-Shuang
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 (02) : 333 - 340
  • [28] Substantia nigra echogenicity correlated with clinical features of Parkinson's disease
    Zhou, Hai-Yan
    Sun, Qian
    Tan, Yu-Yan
    Hu, Yun-Yun
    Zhan, Wei-Wei
    Li, Dun-Hui
    Wang, Ying
    Xiao, Qin
    Liu, Jun
    Chen, Sheng-Di
    PARKINSONISM & RELATED DISORDERS, 2016, 24 : 28 - 33
  • [29] No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease
    Lobsien, Elmar
    Schreiner, Simon
    Plotkin, Michail
    Kupsch, Andreas
    Schreiber, Stephan J.
    Doepp, Florian
    MOVEMENT DISORDERS, 2012, 27 (03) : 450 - 453
  • [30] Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease
    Berg, Daniela
    Behnke, Stefanie
    Seppi, Klaus
    Godau, Jana
    Lerche, Stefanie
    Mahlknecht, Philipp
    Liepelt-Scarfone, Inga
    Pausch, Christoph
    Schneider, Niko
    Gaenslen, Alexandra
    Brockmann, Kathrin
    Srulijes, Karin
    Huber, Heiko
    Wurster, Isabel
    Stockner, Heike
    Kiechl, Stefan
    Willeit, Johann
    Gasperi, Arno
    Fassbender, Klaus
    Gasser, Thomas
    Poewe, Werner
    MOVEMENT DISORDERS, 2013, 28 (02) : 216 - 219